Happiness Biotech Obtained Certification of Covid-19 Testing Kits
Happiness Biotech Group Limited (Nasdaq: HAPP) announced Friday that it has obtained the CE Certification for the company's Covid-19 antibody testing kits on June 5, 2020. The announcement was released after the market closed on Thursday, sending shares of HAPP to $3.00 today before closing at $2.88 per share.
The China-based nutraceutical and dietary supplements producer said the samples of these testing kits have been shipped to countries including Uganda, Malaysia, and Canada since last week.
Xuezhu Wang, the chief executive officer of the Happiness Biotech stated, "We know our investors are keen to receive updated information about our COVID-19 anti-body testing kits and we are proud to announce today what we have accomplished in the past two months."
He added, "The first batch of 10,000 COVID-19 anti-body testing kits is ready for shipment to any clients in the European countries and we will continue to apply for the required approvals in more countries and areas. We hope the orders will start to come soon."
As reported in an article by CapitalWatch's Jennifer Chan, the company announced to develop a Covid-19 testing kit with Fuzhou University in March; Happiness Biotech has been working on a way to develop a more affordable testing kit since January.
Last month, the company reported that sales of 75% alcohol disinfectant and disposable hand sanitizer have exceeded 9 million bottles as of April. Also, sales of daily protective masks have surpassed 2 million pieces.